| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1440-1827.1997.TB04479.X |
| P698 | PubMed publication ID | 9103208 |
| P2093 | author name string | Uchida T | |
| Saitoh T | |||
| Shinzawa H | |||
| P2860 | cites work | RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins | Q24336338 |
| Genetic Variations of the Hepatitis B Virus and Their Clinical Relevance | Q28298591 | ||
| Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX | Q38311755 | ||
| Functional organization of the hepatitis B virus enhancer | Q38340159 | ||
| X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum | Q41225239 | ||
| Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis | Q45767341 | ||
| "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis | Q45782794 | ||
| Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis | Q45784520 | ||
| Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen | Q45849086 | ||
| X protein of hepatitis B virus resembles a serine protease inhibitor | Q45852144 | ||
| Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection | Q45853899 | ||
| P433 | issue | 4 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| P304 | page(s) | 183-193 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Pathology International | Q15758750 |
| P1476 | title | Mutations of the X region of hepatitis B virus and their clinical implications | |
| P478 | volume | 47 |
| Q39218547 | Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations |
| Q36954007 | HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis |
| Q44616955 | High prevalence of occult hepatitis B in Baltimore injection drug users |
| Q36098721 | Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2. |
| Q73520258 | Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B |
| Q27004224 | Occult hepatitis B virus infection |
| Q34768651 | Occult hepatitis B. |
| Q37228545 | Past exposure to hepatitis B: a risk factor for increase in mortality? |
| Q45211512 | Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. |
| Q26823538 | Role of occult hepatitis B virus infection in chronic hepatitis C |
| Q34416288 | Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease |
| Q36720027 | Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma |
| Q42602667 | Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus |
| Q34781813 | Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. |
| Q28070317 | Update on occult hepatitis B virus infection |
| Q36496303 | Viral replication modulated by synthetic peptide derived from hepatitis B virus X protein |
| Q26746928 | X region mutations of hepatitis B virus related to clinical severity |
Search more.